| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/12/2003 | CN1401766A Method for high-efficiency introducing exogenous genetic matter into living cell |
| 03/12/2003 | CN1401657A Gene sequence and use of fish testicle development factor |
| 03/12/2003 | CN1401656A Gene sequence and use of fish testicle development factor |
| 03/12/2003 | CN1401655A Gene sequence and use of embryogenesis regulatory factor in hypophysis of rockfish |
| 03/11/2003 | USRE38028 Administering P. Multocida, P. Haemolytica or H. somnus, a recombinant construct comprising DNA segment and plasmid PBB192 to form transformants |
| 03/11/2003 | US6532462 Gene expression and evaluation system using a filter table with a gene expression database |
| 03/11/2003 | US6531649 Transgenic sugar beet plant expressing cp4/epsps enzyme activity |
| 03/11/2003 | US6531648 Corn and soybean plants expressing thermostabile thioredoxin and/or thioredoxin reductase to enhance extractability and recovery of starch and protein |
| 03/11/2003 | US6531647 Stably-integrated, constitutively expressed, transgenes used to supress homologous endogenous plant genes; tobacco; systemic movement; use strategies for improvement of crop traits |
| 03/11/2003 | US6531646 Genetic modification and improvement of Porphyra species utilizing protoplast fusion; |
| 03/11/2003 | US6531645 RAS/P21 transgenic mouse |
| 03/11/2003 | US6531644 Methods for identifying anti-cancer drug targets |
| 03/11/2003 | US6531587 Retrovirus from the HIV group and its use |
| 03/11/2003 | US6531586 Genetic sequences related to Alzheimer's Disease |
| 03/11/2003 | US6531585 Steroid/thyroid hormone receptor-related gene which is inappropriately expressed in human hepatocellular carcinoma and which is a retinoic acid receptor |
| 03/11/2003 | US6531584 Nuclease resistant oligonucleotide analogs; DNA or RNA modulation; diagnosis, thearpy of viral diseases |
| 03/11/2003 | US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
| 03/11/2003 | US6531456 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 03/11/2003 | US6531451 Isolated antigenic peptide consisting of specified amino acid sequence |
| 03/11/2003 | US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily |
| 03/11/2003 | US6531447 Isolated protein comprising specified amino acid sequence; promotes vascularization |
| 03/11/2003 | US6531316 Encryption of traits using split gene sequences and engineered genetic elements |
| 03/11/2003 | US6531313 Invasive bacterial vectors for expressing alphavirus replicons |
| 03/11/2003 | US6531312 Isolated nucleic acid of given sequence |
| 03/11/2003 | US6531310 Use of microorganisms for processing bioprosthetic tissue |
| 03/11/2003 | US6531309 Which share structural similarity with mammalian ion transporters, calcium transporters (particularly calcium transporting ATPases), sulfate transporters, and zinc transporters |
| 03/11/2003 | US6531307 Capable of activating a compound with little or no toxicity into an active product; use in treating viral diseases, cancer, and genetic disorders |
| 03/11/2003 | US6531303 Method of producing geranylgeraniol |
| 03/11/2003 | US6531302 Using primer pair sets anchored to a microarray through capture sites or through a branched primer pair moiety; allows for simultaneous multiplex capture, amplification, and detection of a target nucleic acid |
| 03/11/2003 | US6531301 Nucleic acid-free thermostable enzymes and methods of production thereof |
| 03/11/2003 | US6531299 Incubating proteins comprising polyketide synthase, butyryl Coenzyme A, and thioester of butyric acid |
| 03/11/2003 | US6531298 Factor IX antihemophilic factor with increased clotting activity |
| 03/11/2003 | US6531297 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 03/11/2003 | US6531295 Isolated nucleic acid encoding polypeptide of given amino acid sequence which serves as a glycosaminoglycan attachment site for heparan sulfate chain |
| 03/11/2003 | US6531294 Producing insulin by expressing a proenzyme in a microorganism by secretion; purifying and converting into the active form by enzymatic treatment |
| 03/11/2003 | US6531292 Genes and proteins controlling cholesterol synthesis |
| 03/11/2003 | US6531289 Modulation of proteins using metal ion-responsive element; use in isolation, screening and analysis of antifungal compounds |
| 03/11/2003 | US6531288 Methods to identify compounds that affect the expression level of the syntaxin-1 A encoding gene |
| 03/11/2003 | US6531284 Subjecting polynucleotide to a two-hybrid screening method (mating); selecting the recombinant diploid yeast cell for which the detectable gene has been expressed |
| 03/11/2003 | US6531283 Protein expression profiling |
| 03/11/2003 | US6531280 Method for identifying or isolating a molecule and molecules identified thereby |
| 03/11/2003 | US6531279 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 03/11/2003 | US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications |
| 03/11/2003 | US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis |
| 03/11/2003 | US6531137 Retrovirus from the HIV group and its use |
| 03/11/2003 | US6531136 Equine rhinovirus 1 proteins |
| 03/11/2003 | US6531135 Administering to the subject an effective amount of a composition comprising a population of infectious, defective alphavirus particles in a pharmaceutically acceptable carrier |
| 03/11/2003 | US6531134 Mammalian milk growth factor |
| 03/11/2003 | US6531133 Pseudomonas exotoxin-myelin basic protein chimeric proteins |
| 03/11/2003 | US6531129 Heparanase specific molecular probes and their use in research and medical applications |
| 03/11/2003 | US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece |
| 03/11/2003 | US6531124 Genetically engineered cells to deliver insulinotropin to stimulate insulin release, to increase insulin sensitivity in peripheral tissues, or to inhibit glucagon secretion from the pancreas |
| 03/11/2003 | US6531123 Safer, yet permit increased efficiency of packaging the recombinant viral genome and increased long-term gene expression |
| 03/11/2003 | CA2112028C Pullulanase, microorganisms producing same, process for preparing this pullulanase and uses thereof |
| 03/11/2003 | CA2050276C Improved primer extension reactions |
| 03/10/2003 | CA2369250A1 Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor |
| 03/06/2003 | WO2003019453A1 Novel sequence conversion methods for the production of overlappingly translated protein sequences (ots) |
| 03/06/2003 | WO2003019451A1 A method and system for defining gene hunting studies |
| 03/06/2003 | WO2003019143A2 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 03/06/2003 | WO2003018854A2 Immobilization of biological molecules onto surfaces coated with monolayers |
| 03/06/2003 | WO2003018844A1 Method and apparatus for three label microarrays |
| 03/06/2003 | WO2003018842A1 Novel gene nedl-1 |
| 03/06/2003 | WO2003018838A2 Interaction detection on several probe arrays |
| 03/06/2003 | WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 03/06/2003 | WO2003018830A2 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE |
| 03/06/2003 | WO2003018828A2 Molecular interaction sites of 16s ribosomal rna and methods of modulating the same |
| 03/06/2003 | WO2003018826A2 Method for producing vitamin b12 |
| 03/06/2003 | WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 03/06/2003 | WO2003018822A1 An improved efficiency (agrobacterium)-mediated wheat transformation method |
| 03/06/2003 | WO2003018821A2 Compositions and methods for treating neurodegenerative diseases |
| 03/06/2003 | WO2003018820A2 Mutant recombinant adeno-associated viruses related applications |
| 03/06/2003 | WO2003018819A1 Method for obtaining transformed corn plants with improved properties of digestibility, resulting corn plants and uses |
| 03/06/2003 | WO2003018818A2 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 03/06/2003 | WO2003018817A1 Yeast membrane protein expression system and its application in drug screening |
| 03/06/2003 | WO2003018816A1 Regulation of human dcamkl1-like serine/threonine protein kinase |
| 03/06/2003 | WO2003018815A2 Regulation of human g protein-couple receptor kinase |
| 03/06/2003 | WO2003018814A2 Enzymes involved in the triacylglycerol biosynthesis in the cytosol of eukaryotes |
| 03/06/2003 | WO2003018813A2 Ashbya gossypii enzymes |
| 03/06/2003 | WO2003018812A1 Regulation of human ptpase-like protein |
| 03/06/2003 | WO2003018811A1 Gene of novel corynebacterium diphtheriae antigen |
| 03/06/2003 | WO2003018810A2 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 03/06/2003 | WO2003018809A2 Isolation of proteins involved in posttranscriptional gene silencing and methods of use |
| 03/06/2003 | WO2003018808A1 PLANT SYSTEM FOR COMPREHENSIVE GENE FUNCTION ANALYSIS WITH THE USE OF FULL-LENGTH cDNA |
| 03/06/2003 | WO2003018807A1 Nucleic acids showing difference in expression between hepatoblastoma anc normal liver |
| 03/06/2003 | WO2003018806A1 Novel human bmcc1 gene |
| 03/06/2003 | WO2003018805A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 03/06/2003 | WO2003018804A1 Proteins having effects of controlling cell migration and cell death |
| 03/06/2003 | WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same |
| 03/06/2003 | WO2003018802A1 Lipophorins |
| 03/06/2003 | WO2003018801A1 Cd36/fat gene promoter and diagnosis of disease associated with cd36/fat gene |
| 03/06/2003 | WO2003018800A2 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene |
| 03/06/2003 | WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/06/2003 | WO2003018798A2 G-protein coupled receptor and dna sequences thereof |
| 03/06/2003 | WO2003018797A2 Method and device for integrated protein expression, purification and detection |
| 03/06/2003 | WO2003018796A1 Oxidative dehalogenation enzyme gene useful for synthesis of optically active 1,2-diol and halogenohydrin and method of mass expression thereof |
| 03/06/2003 | WO2003018791A1 Method of detecting toxic substance |
| 03/06/2003 | WO2003018790A1 Enzyme with the removal activities of the plaques, dna sequence encoding said enzyme, the expressing host cell and methods for producing and purifying said enzyme |
| 03/06/2003 | WO2003018789A1 Esterase est4b1 obtained from bacillus subtilis |
| 03/06/2003 | WO2003018788A2 Improved nitroreductase enzymes |
| 03/06/2003 | WO2003018787A2 Purified human hscas1 gene, polypeptides encoded by hscas1 for o-acetylation of sialic acids and for the diagnosis and prognosis of cancer |